Stockscreener 앱 받기
61.43
2.00%
-1.1599
전일 마감가:
$62.59
열려 있는:
$62.15
하루 거래량:
7.46M
Relative Volume:
0.48
시가총액:
$91.27B
수익:
$20.08B
순이익/손실:
$2.89B
주가수익비율:
31.68
EPS:
1.9391
순현금흐름:
$3.66B
1주 성능:
-2.25%
1개월 성능:
-14.03%
6개월 성능:
-36.04%
1년 성능:
-32.99%
1일 변동 폭
$60.90
$62.26
1주일 범위
$60.90
$64.23
52주 변동 폭
$60.90
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
61.41 | 93.02B | 20.08B | 2.89B | 3.66B | 1.9391 |
ABT
Abbott Laboratories
|
102.66 | 177.76B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.93 | 127.27B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.57 | 110.77B | 35.48B | 4.64B | 5.41B | 3.582 |
EW
Edwards Lifesciences Corp
|
80.94 | 46.81B | 6.07B | 1.06B | 1.34B | 1.8063 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-30 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
BOSTON SCIENTIFIC CORPORATION (BSX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline - TMX Newsfile
Leerink Reiterates Outperform on Boston Scientific (BSX) After CHAMPION-AF Readout - Insider Monkey
Boston Scientific stock hits 52-week low at 61.23 USD - Investing.com
Boston Scientific Corp (NYSE:BSX) Offers Affordable Growth for Value-Conscious Investors - ChartMill
Boston Scientific Corp. stock: Down 35% but analysts see rebound potential - AD HOC NEWS
Boston Scientific (BSX) Price Target Lowered by Evercore ISI Gro - GuruFocus
Boston Scientific closes buyout of Valencia Technologies - MedTech Dive
BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Piper Sandler maintains Boston Scientific stock rating after device feedback - Investing.com
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Nike, Boston Scientific, And Sysco Are Among Top 10 Large Cap Losers Last Week (March 30-April 2): Are th - Benzinga
Boston Scientific Corporation (BSX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Boston Scientific Corporation (BSX) stock price, news, quote and history - Yahoo Finance Singapore
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Why Boston Scientific's big dip could be a bigger opportunity - MSN
Boston Scientific beats Q4 estimates, shares dip slightly - Investing.com
Boston Scientific Corp. Stock: Strong Growth in Medtech Amid Evolving Healthcare Demands - AD HOC NEWS
Boston Scientific Corp. stock outperforms competitors on strong trading day - marketwatch.com
Boston Scientific completes acquisition of California bladder treatment company - Worcester Business Journal
BSX Shareholders Have Opportunity to Lead Boston Scientific Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - ChartMill
INVESTOR DEADLINE: Boston Scientific Corporation (BSX) - globenewswire.com
RBC Capital reiterates Boston Scientific stock rating on growth outlook By Investing.com - Investing.com India
RBC Capital reiterates Boston Scientific stock rating on growth outlook - Investing.com
Here are the largest manufacturers in Massachusetts - The Business Journals
Banque Pictet & Cie SA Has $25.83 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
BSX Stock Price, Quote & Chart | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill
[EFFECT] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Boston Scientific (NYSE: BSX) to acquire Penumbra in $374/share deal - Stock Titan
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Boston Scientific (BSX) Says CHAMPION-AF Trial Meets All Primary Endpoints - Insider Monkey
Boston Scientific (XSWX:BSX) Shiller PE Ratio : (As of Apr. 01, 2026) - GuruFocus
Nisa Investment Advisors LLC Sells 18,182 Shares of Boston Scientific Corporation $BSX - MarketBeat
List of 57 Acquisitions by Boston Scientific (Apr 2026) - Tracxn
Stocks making big moves yesterday: Avis Budget Group, Boston Scientific, CLEAR Secure, DNOW, and Comcast - Yahoo Finance
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - ChartMill
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
Boston Scientific presents Watchman FLX and EKOS endovascular system data - Medical Device Network
FDA clears Boston Scientific’s Asurys system for endoscopic procedures - Medical Device Network
UBS reiterates Boston Scientific stock Buy on trial success - Investing.com
Boston Scientific (BSX) Stock Plunges 9% on Watchman Trial Concerns and Rating Cut - Blockonomi
Boston Scientific (BSX) Stock Falls 9% After Watchman Trial Data and Analyst Downgrade - CoinCentral
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Abbott Laboratories (ABT) - theglobeandmail.com
Jefferies Keeps Their Buy Rating on Boston Scientific (BSX) - theglobeandmail.com
Boston Scientific (BSX) Gets a Buy from Canaccord Genuity - theglobeandmail.com
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
BSX CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
BSX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Boston Scientific Corporation Securities Lawsuit -- The Gross Law Firm - PR Newswire
Boston Scientific Stock Sinks to 2-Year Low. Why Wall Street Is Souring on Trial Data. - Barron's
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.20%
0.26%
자본화:
|
볼륨(24시간):